Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Pfizer's FY2024 revenue of USD 63.6 billion represents significant decline from its COVID-era peak above USD 100 billion but confirms its standing as a large-scale pharmaceutical company with strong oncology growth (Padcev/enfortumab vedotin, an antibody-drug conjugate, achieved rapid adoption in bladder cancer)
What the Hell Is BPC-157
While compounded formulations differ from branded products, the core safety and efficacy data derive from these FDA-reviewed documents
Animal data is more robust
US$ 27.53
US$ 25.28
US$ 21.88
